abagovomab 22
abciximab 24
abituzumab 20
abrilumab 19
actoxumab 13
adalimumab 17
aducanumab 9
afasevikumab 14
alacizumab_pegol 11
alemtuzumab 22
alirocumab 17
amatuximab 33
andecaliximab 18
anifrolumab 19
anrukinzumab 18
aprutumab 12
aprutumab_ixadotin 12
arcitumomab 21
ascrinvacumab 7
atezolizumab 15
atinumab 14
avelumab 13
basiliximab 23
bavituximab 32
begelomab 21
benralizumab 24
bevacizumab_beta 19
bezlotoxumab 13
bimagrumab 10
bleselumab 12
blinatumomab 29
blosozumab 27
bococizumab 15
brazikumab 15
brentuximab_vedotin 24
briakinumab 15
brodalumab 8
brolucizumab 22
brontictuzumab 23
burosumab 17
cabiralizumab 24
camrelizumab 11
canakinumab 20
cantuzumab_ravtansin 43
carlumab 12
carotuximab 26
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 24
cetiximab 42
citatuzumab_bogatox 26
cixutumumab 20
clivatuzumab_tetraxetan 17
codrituzumab 29
conatumumab 9
concizumab 28
crenezumab 18
crizanlizumab 23
crotedumab 19
dacetuzumab 21
daclizumab 10
dalotuzumab 31
dapirolizumab_pegol 23
daratumumab 14
dectrekumab 8
demcizumab 19
denosumab 10
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 18
dinutuximab 34
diridavumab 15
domagrozumab 13
drozitumab 13
duligotuzumab 19
durvalumab 4
dusigitumab 8
efalizumab 29
efungumab 26
eldelumab 13
elezanumab 16
elgemtumab 11
elotuzumab 11
emactuzumab 16
emapalumab 25
emibetuzumab 14
enavatuzumab 23
enfortumab_vedotin 11
enoblituzumab 16
enokizumab 21
enoticumab 17
ensituximab 27
eptinezumab 17
erenumab 16
etaracizumab 15
etrolizumab 22
evinacumab 21
evolocumab 11
farletuzumab 8
fasinumab 20
fezakinumab 14
fibatuzumab 7
ficlatuzumab 18
firivumab 33
flanvotumab 17
fletikumab 15
foralumab 10
foravirumab 12
fremanezumab 26
fresolimumab 17
fulranumab 19
futuximab 21
galcanezumab 17
ganitumab 25
gantenerumab 11
gemetuzumab 23
gemtuzumab2 25
gemtuzumab 19
gevokizumab 20
girentuximab 27
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 20
ibalizumab 24
ibritumomab 28
icrucumab 8
idarucizumab 32
ifabotuzumab 7
imalumab 17
imgatuzumab 19
inclacumab 17
indatuximab_ravtansin 28
indusatumab 11
inebilizumab 22
intetumumab 10
iodine_girentuximab 28
ipilimumab 3
iratumumab 6
isatuximab 32
itolizumab 24
ixekizumab 30
labetuzumab_govitecan 15
lambrolizumab 20
lampalizumab 21
lanadelumab 17
landogrozumab 17
laprituximab 22
lebrikizumab 33
lendalizumab 22
lenzilumab 13
lifastuzumab_vedotin 25
ligelizumab 20
lilotomab 32
lirilumab 21
lodelcizumab 16
lokivetmab 23
lorvotuzumab_mertansin 24
lucatumumab 27
lumretuzumab 15
lupartumab 10
lutikizumab 20
margetuximab 29
milatuzumab 37
mirvetuximab 28
mirvetuximab_soravtansin 28
modotuximab 32
mogamulizumab 31
monalizumab 16
motavizumab 26
moxetumomab_pasudotox 31
namilumab 14
naratuximab 23
naratuximab_emtansin 23
narnatumab 14
navicixizumab2 25
navicixizumab 22
navivumab 31
necitumumab 10
nemolizumab 24
nesvacumab 14
nivolumab 12
obiltoxaximab 20
obinutuzumab 34
ocaratuzumab 25
ofatumumab 18
olaratumab 19
olokizumab 24
omalizumab 19
onartuzumab 20
ontuxizumab 22
opicinumab 14
orticumab 13
otelixizumab 34
oxelumab 11
ozanezumab 28
pamrevlumab 10
panobacumab 27
parsatuzumab 24
pasotuxizumab 20
pateclizumab 14
patritumab 17
pembrolizumab 20
perakizumab 21
pidilizumab 16
pinatuzumab_vedotin 16
plozalizumab 31
pogalizumab 22
polatuzumab_vedotin 20
ponezumab 36
prezalumab 12
pritoxaximab 27
quilizumab 19
racotumomab 25
radretumab 14
ralpancizumab 20
ramucirumab 14
ranevetmab 27
ranibizumab 22
refanezumab 21
remtolumab 17
rilotumumab 12
rinucumab 17
risankizumab 32
rituximab 17
rivabazumab 17
robatumumab 20
roledumab 23
romosozumab 18
rontalizumab 19
rosmantuzumab 20
rozanolixizumab 20
sacituzumab 24
sacituzumab_govitecan 24
samalizumab 22
sapelizumab 22
sarilumab 16
secukinumab 9
seribantumab 17
setoxaximab 39
sifalimumab 7
siltuximab 25
simtuzumab 24
sirukumab 9
solanezumab 25
solitomab 22
stamulumab 15
suptavumab 19
suvizumab 15
tabalumab 9
tadocizumab 14
tamtuvetmab 30
tanezumab 21
tarextumab 11
tavolixizumab 17
telisotuzumab 25
teplizumab 15
tesidolumab 18
tezepelumab 22
tigatuzumab 17
tildrakizumab 18
timolumab 13
tisotumab 11
tosatoxumab 32
tositumomab 28
tralokinumab 22
trastuzumab 22
tregalizumab 23
trevogrumab 12
ublituximab 27
urelumab 15
ustekinumab 25
utomilumab 24
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 14
vantictumab 19
vanucizumab2 19
vanucizumab 25
varlilumab 12
vatelizumab 19
vedolizumab 19
veltuzumab 13
vesencumab 12
vorsetuzumab 18
vorsetuzumab_mafodotin 18
vunakizumab 28
xentuzumab 16
zatuximab 32
